| Title |
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
|
|---|---|
| Published in |
BMC Psychiatry, September 2013
|
| DOI | 10.1186/1471-244x-13-241 |
| Pubmed ID | |
| Authors |
Erik Johnsen, Igne Sinkeviciute, Else-Marie Løberg, Rune A Kroken, Kenneth Hugdahl, Hugo A Jørgensen |
| Abstract |
Hallucinations are prevalent in schizophrenia and related psychotic disorders and may have severe consequences for the affected patients. Antipsychotic drug trials that specifically address the anti-hallucinatory effectiveness of the respective drugs in representative samples are rare. The aims of the present study were to investigate the rate and severity of hallucinations in acutely admitted psychotic patients at hospital admission and discharge or after 6 weeks at the latest, if not discharged earlier (discharge/6 weeks); and to compare the anti-hallucinatory effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone with up to 2 years' follow-up. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Unknown | 69 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 17% |
| Student > Ph. D. Student | 9 | 13% |
| Researcher | 6 | 9% |
| Other | 6 | 9% |
| Student > Doctoral Student | 5 | 7% |
| Other | 12 | 17% |
| Unknown | 20 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 14 | 20% |
| Medicine and Dentistry | 13 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 10% |
| Nursing and Health Professions | 4 | 6% |
| Arts and Humanities | 2 | 3% |
| Other | 5 | 7% |
| Unknown | 25 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2014.
All research outputs
#18,349,015
of 23,577,654 outputs
Outputs from BMC Psychiatry
#3,864
of 4,896 outputs
Outputs of similar age
#149,112
of 207,537 outputs
Outputs of similar age from BMC Psychiatry
#65
of 80 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,896 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.7. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,537 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.